Related Experiment Video
Updated: Jul 25, 2025
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.2K
Advances in immunotherapy for gynecological malignancies
1Women's Reproductive Health Laboratory of Zhejiang Province, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China.
Critical Reviews in Oncology/Hematology
|June 29, 2023
Summary
Immunotherapy shows promise for gynecological cancers, offering better antitumor activity than traditional treatments. Further research and clinical trials are needed to fully realize its potential in treating advanced or resistant cancers.
Area of Science:
- Gynecological Oncology
- Cancer Immunotherapy
- Translational Medicine
Background:
- Current treatments for gynecological malignancies (surgery, chemotherapy, radiotherapy) have limitations, especially for advanced or resistant cancers.
- Complicated cases like advanced cervical and endometrial cancer (EC), chemotherapy-resistant gestational trophoblastic neoplasia, and platinum-resistant ovarian cancer pose significant challenges.
- Immunotherapy presents a promising alternative with potential for improved antitumor activity and reduced toxicity.
Purpose of the Study:
- To review the current landscape and recent advancements in immunotherapy for gynecological malignancies.
- To discuss the challenges hindering the clinical application of gynecological cancer immunotherapy.
- To explore future directions for immunotherapy in treating these cancers.
Main Methods:
- Comprehensive literature review of preclinical studies and clinical trials.
- Analysis of immunotherapy's efficacy and safety in gynecological cancer contexts.
- Discussion of existing challenges and future research needs.
Main Results:
- Immunotherapy demonstrates potential to enhance prognosis in patients with gynecological malignancies.
- It offers improved antitumor effects compared to conventional therapies.
- While promising, immunotherapy's development lags behind clinical needs, necessitating further investigation.
Conclusions:
- Immunotherapy is a developing and viable alternative for treating gynecological malignancies, particularly advanced or resistant types.
- Significant progress is being made, but more extensive preclinical research and large-scale clinical trials are essential.
- Addressing current challenges will pave the way for broader clinical adoption and improved patient outcomes.
More Related Videos
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.5K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
Related Concept Videos
01:27Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
01:30Cancer Vaccines
428
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
428
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K